share_log

BTIG Maintains Buy on Organogenesis Hldgs, Raises Price Target to $6

Benzinga ·  Dec 27, 2023 07:27

BTIG analyst Ryan Zimmerman maintains Organogenesis Hldgs (NASDAQ:ORGO) with a Buy and raises the price target from $4 to $6.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment